Dr. Hildebrand is CEO of Nantiox, a local startup working on nanotechnology to prevent blindness caused by retinal diseases such as age-related macular degeneration, glaucoma and diabetic retinopathy.
He and Jim McGinnis, MD, professor of ophthalmology at the University of Oklahoma Health Sciences Center and lead researcher on the project, have been quite successful securing state and federal grants for the company.
Related Articles on Medical Innovation:
LA Times: Patients Should Research Ties Between Physicians and Drug Firms
Microscope Can See in Nano-Detail Using Algorithm Like Hubble Telescope’s
New Gas Connector Reduces Risk of Misconnection
